Posts in category

News


The Generic and Biosimilar Medicines Association has welcomes the recommendation by the PBAC to list biosimilar infliximab (Inflectra) on the PBS and to recommend the marking as equivalent, also known …

In a few weeks, hundreds of pharmacy assistants will make their way to the Gold Coast for the annual Pharmacy Assistant National Conference (PA2015); allowing them to attend can be …

Medicines Australia has expressed concern about the PBAC’s recommendation that pharmacists be allowed to substitute the biosimilars in place of biologic medicines prescribed by a patient’s doctor. “The so-called ‘a-flagging’ …

The Federal Government needs to list new hepatitis C medicines on the PBS without further delay, according to the peak body representing the interests of a quarter of a million …

Three Australian research teams have been awarded grants as part of a global effort to combat the growing incidence of type 2 diabetes, which affects more than 300 million people …

The PBAC today recommended that Inflectra (infliximab), the first monoclonal antibody ‘mAb’ biosimilar registered in Australia, be added to the Pharmaceutical Benefits Scheme. The recommendation is the first step towards …

Working more than 55 hours is linked to a huge increased risk of stroke and also coronary heart disease, according to a study published in The Lancet. The study—the largest …

Eltham pharmacist Michael Williams has taken out the title of fastest pharmacist, winning the Medici Capital Pharmacy Ski Race for 2015. The annual race was held at Mt Buller this …

Research by The University of Western Australia’s Centre for Health and Ageing has confirmed that the incidence of dementia in remote Aboriginal communities is the highest in the world, with …

Discount Drug Stores is urging Australians to become educated on their breast health by launching its first Spotlight On Breast Health Clinics throughout 115 stores across Australia in August and …

The Generic and Biosimilar Medicines Association has welcomed the approval of biosimilar infliximab, Inflectra. Inflectra is the first biosimilar infliximab to be approved in Australia, providing an alternative, affordable treatment …

University of Adelaide researchers have discovered a high-fat diet may impair important receptors located in the stomach that signal fullness. Published in the journal PLOS ONE, researchers from the University’s …